Clinical outcome study of crizotinib in IHC proven EML4-ALK fusion gene among Indian patients with adenocarcinoma lung

被引：0
|
作者：
Batra, U. [1 ]
Sharma, M. [2 ]
Jain, A. [1 ]
Agarwal, M. [1 ]
Goyal, P. [2 ]
机构：
[1] Rajiv Gandhi Canc Inst & Res Ctr, Med Oncol, New Delhi, India
[2] Rajiv Gandhi Canc Inst, Med Oncol, Delhi, India
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
469P
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Clinical effect of crizotinib on lung cancer patients with EML4-ALK fusion gene mutation
    Wang, Zhiyong
    Wang, Wei
    Kong, Xiaodong
    Li, Guangxu
    Yang, Weiwei
    [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (09): : 11632 - 11638
  • [2] Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung
    Doval, D. C.
    Prabhash, K.
    Patil, S.
    Chaturvedi, H.
    Goswami, C.
    Vaid, A. K.
    Desai, S.
    Dutt, S.
    Veldore, V. H.
    Jambhekar, N.
    Mehta, A.
    Hazarika, D.
    Azam, S.
    Gawande, S.
    Gupta, S.
    [J]. ONCOTARGETS AND THERAPY, 2015, 8 : 117 - 123
  • [3] EML4-ALK FUSION GENE IN LUNG ADENOCARCINOMA IN THAILAND
    Prempree, Thongbliew
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1023 - S1024
  • [4] A CASE OF LUNG ADENOCARCINOMA RESISTANT TO CRIZOTINIB HARBORING KRAS MUTATION AND EML4-ALK FUSION GENE
    Anai, Satoshi
    Suzuki, Kunihiro
    Sueishi, Katsuo
    Harada, Taishi
    Toyokawa, Gouji
    Seto, Takashi
    Takenoyama, Mitsuhiro
    Takayama, Koichi
    Ichinose, Yukito
    Nakanishi, Yoichi
    [J]. ANNALS OF ONCOLOGY, 2014, 25
  • [5] A CASE OF LUNG ADENOCARCINOMA HARBORING BOTH A KRAS MUTATION AND AN EML4-ALK FUSION GENE WITH RESPONSE TO CRIZOTINIB
    Menefee, Michael E.
    D'Amico, Thomas A.
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1315 - S1316
  • [6] Outcome of two patients harboring EML4-ALK fusion gene with brain metastasis treated with crizotinib
    Okimoto, Tamio
    Tsubata, Yukari
    Nakao, Mika
    Koba, Naoya
    Hotta, Takamasa
    Hamaguchi, Megumi
    Hamaguchi, Shunnichi
    Sutani, Akihisa
    Hamada, Akinobu
    Isobe, Takeshi
    [J]. ANNALS OF ONCOLOGY, 2015, 26 : 137 - 138
  • [7] The Prevalence of the EML4-ALK Fusion Gene in Cytology Specimens from Patients with Lung Adenocarcinoma
    Heriyanto, Didik S.
    Trisnawati, Ika
    Kumara, Evan G.
    Laiman, Vincent
    Yuliani, Fara S.
    Sumpono, Auliya S. B.
    Cempaka, Rita
    Marcellus
    Budiono, Eko
    [J]. PULMONARY MEDICINE, 2020, 2020
  • [8] EML4-ALK Fusion in Lung
    Mano, Hiroyuki
    Takeuchi, Kengo
    [J]. AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (03): : 1552 - 1553
  • [9] Crizotinib for EML4-ALK positive lung adenocarcinoma: a hope for the advanced disease?
    Antoniu, Sabina Antonela
    [J]. EXPERT OPINION ON THERAPEUTIC TARGETS, 2011, 15 (03) : 351 - 353
  • [10] A case of lung adenocarcinoma harboring EGFR mutation and EML4-ALK fusion gene
    Tanaka, Hisashi
    Hayashi, Akihito
    Morimoto, Takeshi
    Taima, Kageaki
    Tanaka, Yoshihito
    Shimada, Michiko
    Kurose, Akira
    Takanashi, Shingo
    Okumura, Ken
    [J]. BMC CANCER, 2012, 12
12345